Cassiopea S.p.A. | Income Statement

Fiscal year is January-December. All values CHF Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
19.70
21.90
16.00
27.20
33.30
45
Gross Income
19.70
21.90
16.00
27.20
33.30
45
SG&A Expense
5,397.00
4,736.80
8,907.20
17,775.50
16,114.30
16,269.10
EBIT
5,416.70
4,758.60
8,923.30
17,802.80
16,147.60
16,314.20
Non Operating Income/Expense
25.90
58.30
2,001.00
814.10
3,549.30
430.70
Interest Expense
139.10
14.60
-
-
-
-
Pretax Income
5,529.90
4,714.90
6,888.10
16,759.90
19,401.60
15,669.90
Income Tax
1,665.30
1,344.20
-
6,411.20
4,240.90
1,057.60
Consolidated Net Income
3,864.70
3,370.70
6,888.10
10,348.60
15,160.70
14,612.30
Net Income
3,864.70
3,370.70
6,888.10
10,348.60
15,160.70
14,612.30
Net Income After Extraordinaries
3,864.70
3,370.70
6,888.10
10,348.60
15,160.70
14,612.30
Net Income Available to Common
3,864.70
3,370.70
6,888.10
10,348.60
15,160.70
14,612.30
EPS (Basic)
0.39
0.34
1.19
1.04
1.52
1.46
Basic Shares Outstanding
10,000.00
10,000.00
5,795.90
10,000.00
10,000.00
10,000
EPS (Diluted)
0.39
0.34
1.19
1.03
1.52
1.46
Diluted Shares Outstanding
10,000.00
10,000.00
5,803.50
10,000.00
10,000.00
10,000
EBITDA
5,397.00
4,736.80
8,907.20
17,775.60
16,114.30
16,269.10
Non-Operating Interest Income
-
-
34.20
228.90
295.30
213.60

About Cassiopea

View Profile
Address
Via Cristoforo Colombo, 1
Milan Milan 20020
Italy
Employees -
Website http://www.cassiopea.com
Updated 07/08/2019
Cassiopea SpA is a clinical-stage specialty pharmaceutical company. It engages in developing and commercializing and medical dermatology products focusing on the topical treatment of acne, androgenic alopecia, and genital warts. The company products include Winlevi, Breezula, CB-06-02 and CB-06-01.